As the new year has arrived, the ID CARE Committee would like to share some of the accomplishments we have had in 2023, along with on-going initiatives to look forward to as the year progresses.
Since our last newsletter, our members presented a poster at the 2023 American Transplant Congress on preventive strategies for Toxoplasma gondii after transplantation. While trimethoprim sulfamethoxazole is the most common drug employed for prevention, perhaps not too surprising, the dosing used, and duration of prophylaxis were highly variable among different centers and organ types. Dr. Ben Hanish, a former member of the ID CARE Committee and part of the IPTA ID Community, led the initiative and is finishing a manuscript that is currently in draft form. So be on the lookout for it in coming months!
Several former and current members of the ID CARE group are analyzing data from an IPTA survey on prophylaxis strategies used after pediatric liver transplantation. This was put into abstract form by Dr. Lara Danziger-Isakov and submitted to ATC 2024. We are optimistic that it will be accepted so please support your colleagues. If you attend the ATC, be on the lookout for that poster and stop by to enjoy it and share your thoughts.
Collaboration is a vital aspect of IPTA, and the ID CARE group has always valued the strategic importance of collaboration. Towards this end one of our first official collaborations with the broader ID community of experts is to formulate case based practical guidelines on dealing with tuberculosis before and after transplantation under the leadership of Dr. Upton Allen.
We are delighted that our member Jessica Brennan is leading a collaboration with the Allied Professional committee to develop safe living strategies for adolescents and teens after transplantation. The teenage years are often filled with angst and a of feeling of invincibility which is counter to good decision-making, particularly after transplantation. For this reason, we think having some practical guidance to help during this period will be valuable.
A request came from outside the ID CARE Committee to help with pointers dealing with our patients who have anatomic or functional asplenia. This is particularly timely as new vaccines are available in some countries against pneumococcus and meningococcus. With this in mind, our ID CARE Committee Fellow member, Dr. Gabriela Espinoza-Candelaria, is taking the lead on this project and is a reminder to all trainees that you too can be active in IPTA.
Other infectious disease topics being tackled by the group include cholangitis guidelines and review of increased numbers of pneumocystis cases in our patients.
Finally, it seems that the ID members were so busy caring for children with respiratory viruses this year that we were too late to put out guidance. But fear not - in the Spring we will start to have our group review updates on prevention and the immunology of severe infection.
So, stay tuned, and remember - wash your hands, promote vaccination for prevention of infection, and stay healthy!